Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
June 22 2020
Discover the interview of Séverine Sigrist, the Chief Executive and Scientific Officer of Def...
June 16 2020
A video to better understand the medical device ExOlin®! To understand how the ExOlin® device...